Atomwise is a San Francisco-based company that utilizes artificial intelligence (AI) to revolutionize the process of drug discovery, resulting in the development of more effective medications. Their AI engine combines convolutional neural networks with extensive chemical libraries to identify new small molecule medicines, and their portfolio includes both wholly owned and co-developed pipeline assets.
With a focus on tackling the most challenging problems in the field, Atomwise is dedicated to developing the best AI platform and leveraging it to transform the landscape of small molecule drug discovery. Their team of experts is committed to pushing the boundaries of innovation in the pharmaceutical industry, making Atomwise a leading force in the development of new drugs.
Generated from the website